TARPLIN, DOWNS & YOUNG, LLC

Lobbying for ABBVIE INC. · Abbvie is a global biopharmaceutical company focused on developing leading-edge therapies.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Illinois · House · Senate · $60,000.00 income · posted Jan 20, 2026

Lobbying activity 3

Health Issues

drug pricing in federal programs, transparency, prescription drug pricing and access, beneficiary access, IRA

Medicare/Medicaid

Part B, Part D, drug pricing and access, negotiation,

Budget/Appropriations

federal budget issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.